The Pisgah Fund is an early-stage venture capital fund focused on investing in innovative healthcare companies and supporting long-term economic growth in Western North Carolina (WNC). Managed by Hatteras Venture Partners, the Fund backs innovative healthcare businesses that improve care delivery and expand access, partnering with founders to build durable companies rooted in or connected to the region.
The WakeMed Innovation Venture Fund brings together community-serving health systems to make strategic investments in technologies that enhance care delivery and generate attractive returns – all under the trusted guidance of Hatteras Venture Partners.
Carolina Research Ventures provides critical early-stage investments to startups emerging from UNC-Chapel Hill research. It channels capital into translating academic innovations into successful commercial ventures.
The State-funded Venture Capital Multiplier Fund (or “VCMF”) is a pool of capital allocated to co-investments in North Carolina Nexus companies. NC Nexus companies are those that: a) are headquartered in NC, b) have significant operations in NC, c) are commercializing intellectual property developed in NC, or d) as a result of investment, would initiate, expand, or restructure significant operations in NC. These investments are either co-investments in NC Nexus Hatteras portfolio companies, or investments made alongside institutional funds with whom Hatteras has established a co-investing relationship.